472 related articles for article (PubMed ID: 11740733)
21. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
[TBL] [Abstract][Full Text] [Related]
22. Protective immune responses to a multi-gene DNA vaccine against Staphylococcus aureus.
Gaudreau MC; Lacasse P; Talbot BG
Vaccine; 2007 Jan; 25(5):814-24. PubMed ID: 17027124
[TBL] [Abstract][Full Text] [Related]
23. Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence.
Josefsson E; Higgins J; Foster TJ; Tarkowski A
PLoS One; 2008 May; 3(5):e2206. PubMed ID: 18493318
[TBL] [Abstract][Full Text] [Related]
24. Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A.
Narita K; Hu DL; Mori F; Wakabayashi K; Iwakura Y; Nakane A
Infect Immun; 2010 Oct; 78(10):4234-42. PubMed ID: 20679443
[TBL] [Abstract][Full Text] [Related]
25. Virulence potential of the staphylococcal adhesin CNA in experimental arthritis is determined by its affinity for collagen.
Xu Y; Rivas JM; Brown EL; Liang X; Höök M
J Infect Dis; 2004 Jun; 189(12):2323-33. PubMed ID: 15181582
[TBL] [Abstract][Full Text] [Related]
26. Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection.
Cui JC; Hu DL; Lin YC; Qian AD; Nakane A
FEMS Immunol Med Microbiol; 2005 Jul; 45(1):45-51. PubMed ID: 15985222
[TBL] [Abstract][Full Text] [Related]
27. DNA immunization against the clumping factor A (ClfA) of Staphylococcus aureus.
Brouillette E; Lacasse P; Shkreta L; Bélanger J; Grondin G; Diarra MS; Fournier S; Talbot BG
Vaccine; 2002 May; 20(17-18):2348-57. PubMed ID: 12009291
[TBL] [Abstract][Full Text] [Related]
28. [Characterization of antiserum after co-immunized with adhesins expressing ClfA, FnBPA-A and FnBPA-BCD of Staphylococus aureus].
Jiang H; Su Y; Shen Y
Wei Sheng Wu Xue Bao; 2015 Oct; 55(10):1343-9. PubMed ID: 26939463
[TBL] [Abstract][Full Text] [Related]
29. Mucosal genetic immunization against four adhesins protects against Staphylococcus aureus-induced mastitis in mice.
Castagliuolo I; Piccinini R; Beggiao E; Palù G; Mengoli C; Ditadi F; Vicenzoni G; Zecconi A
Vaccine; 2006 May; 24(20):4393-402. PubMed ID: 16580097
[TBL] [Abstract][Full Text] [Related]
30. Capsular polysaccharide masks clumping factor A-mediated adherence of Staphylococcus aureus to fibrinogen and platelets.
Risley AL; Loughman A; Cywes-Bentley C; Foster TJ; Lee JC
J Infect Dis; 2007 Sep; 196(6):919-27. PubMed ID: 17703424
[TBL] [Abstract][Full Text] [Related]
31. Vaccination with clumping factor A and fibronectin binding protein A to prevent Staphylococcus aureus infection of an aortic patch in mice.
Arrecubieta C; Matsunaga I; Asai T; Naka Y; Deng MC; Lowy FD
J Infect Dis; 2008 Aug; 198(4):571-5. PubMed ID: 18613794
[TBL] [Abstract][Full Text] [Related]
32. Fibronectin-binding proteins and fibrinogen-binding clumping factors play distinct roles in staphylococcal arthritis and systemic inflammation.
Palmqvist N; Foster T; Fitzgerald JR; Josefsson E; Tarkowski A
J Infect Dis; 2005 Mar; 191(5):791-8. PubMed ID: 15688297
[TBL] [Abstract][Full Text] [Related]
33. Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.
Higgins J; Loughman A; van Kessel KP; van Strijp JA; Foster TJ
FEMS Microbiol Lett; 2006 May; 258(2):290-6. PubMed ID: 16640587
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a novel chimeric B cell epitope-based vaccine against mastitis induced by either Streptococcus agalactiae or Staphylococcus aureus in mice.
Xu H; Hu C; Gong R; Chen Y; Ren N; Xiao G; Xie Q; Zhang M; Liu Q; Guo A; Chen H
Clin Vaccine Immunol; 2011 Jun; 18(6):893-900. PubMed ID: 21508165
[TBL] [Abstract][Full Text] [Related]
35. A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure.
Hawkins J; Kodali S; Matsuka YV; McNeil LK; Mininni T; Scully IL; Vernachio JH; Severina E; Girgenti D; Jansen KU; Anderson AS; Donald RG
Clin Vaccine Immunol; 2012 Oct; 19(10):1641-50. PubMed ID: 22896688
[TBL] [Abstract][Full Text] [Related]
36. Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models.
Yang L; Cai C; Feng Q; Shi Y; Zuo Q; Yang H; Jing H; Wei C; Zhuang Y; Zou Q; Zeng H
Sci Rep; 2016 Feb; 6():20929. PubMed ID: 26865417
[TBL] [Abstract][Full Text] [Related]
37. Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against Staphylococcus aureus infection.
Narita K; Hu DL; Tsuji T; Nakane A
FEMS Immunol Med Microbiol; 2008 Apr; 52(3):389-96. PubMed ID: 18312579
[TBL] [Abstract][Full Text] [Related]
38. Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.
Delfani S; Mohabati Mobarez A; Imani Fooladi AA; Amani J; Emaneini M
Med Microbiol Immunol; 2016 Feb; 205(1):47-55. PubMed ID: 26155981
[TBL] [Abstract][Full Text] [Related]
39. On the role of Staphylococcus aureus sortase and sortase-catalyzed surface protein anchoring in murine septic arthritis.
Jonsson IM; Mazmanian SK; Schneewind O; Verdrengh M; Bremell T; Tarkowski A
J Infect Dis; 2002 May; 185(10):1417-24. PubMed ID: 11992276
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice.
Tuchscherr LP; Buzzola FR; Alvarez LP; Lee JC; Sordelli DO
Infect Immun; 2008 Dec; 76(12):5738-44. PubMed ID: 18809660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
